25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$
Buy, Hold or Sell?

Let's analyze BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ together

I guess you are interested in BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$

I send you an email if I find something interesting about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

1. Quick Overview

1.1. Quick analysis of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ (30 sec.)










1.2. What can you expect buying and holding a share of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR20.43
Expected worth in 1 year
INR4.55
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
INR-15.88
Return On Investment
-66.5%

For what price can you sell your share?

Current Price per Share
INR23.87
Expected price per share
INR22.25 - INR30.30
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ (5 min.)




Live pricePrice per Share (EOD)
INR23.87
Intrinsic Value Per Share
INR-58.83 - INR-70.77
Total Value Per Share
INR-38.40 - INR-50.34

2.2. Growth of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ (5 min.)




Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ growing?

Current yearPrevious yearGrowGrow %
How rich?$10.4m$12.4m-$2m-19.4%

How much money is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$1m-$930.4k-47.4%
Net Profit Margin-37.3%-11.2%--

How much money comes from the company's main activities?

2.3. Financial Health of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$?

Welcome investor! BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$'s management wants to use your money to grow the business. In return you get a share of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

First you should know what it really means to hold a share of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$. And how you can make/lose money.

Speculation

The Price per Share of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is INR23.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR20.43. Based on the TTM, the Book Value Change Per Share is INR-3.97 per quarter. Based on the YOY, the Book Value Change Per Share is INR16.51 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.05-0.2%-0.05-0.2%-0.02-0.1%-0.03-0.1%-0.03-0.1%
Usd Book Value Change Per Share-0.05-0.2%-0.05-0.2%0.190.8%0.050.2%0.050.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-0.2%-0.05-0.2%0.190.8%0.050.2%0.050.2%
Usd Price Per Share0.26-0.26-0.33-0.26-0.26-
Price to Earnings Ratio-5.76--5.76--13.86--7.73--7.73-
Price-to-Total Gains Ratio-5.59--5.59-1.70-1.84-1.84-
Price to Book Ratio1.09-1.09-1.15-2.06-2.06-
Price-to-Total Gains Ratio-5.59--5.59-1.70-1.84-1.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.281666
Number of shares3550
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.05
Usd Total Gains Per Share-0.050.05
Gains per Quarter (3550 shares)-166.27171.16
Gains per Year (3550 shares)-665.07684.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-665-6750685675
20-1330-1340013691360
30-1995-2005020542045
40-2660-2670027392730
50-3325-3335034233415
60-3990-4000041084100
70-4655-4665047924785
80-5321-5330054775470
90-5986-5995061626155
100-6651-6660068466840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.969-3.9690%16.515-124%4.086-197%4.086-197%
Book Value Per Share--20.42920.4290%24.399-16%12.912+58%12.912+58%
Current Ratio--0.3810.3810%0.646-41%0.719-47%0.719-47%
Debt To Asset Ratio--0.5320.5320%0.505+5%0.661-19%0.661-19%
Debt To Equity Ratio--1.1391.1390%1.019+12%2.496-54%2.496-54%
Dividend Per Share----0%-0%-0%-0%
Eps---3.853-3.8530%-2.027-47%-2.756-28%-2.756-28%
Free Cash Flow Per Share--2.5232.5230%-9.753+487%-0.810+132%-0.810+132%
Free Cash Flow To Equity Per Share--2.5232.5230%-9.753+487%0.612+312%0.612+312%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---70.765--------
Intrinsic Value_10Y_min---58.827--------
Intrinsic Value_1Y_max---2.712--------
Intrinsic Value_1Y_min---2.636--------
Intrinsic Value_3Y_max---11.487--------
Intrinsic Value_3Y_min---10.789--------
Intrinsic Value_5Y_max---24.285--------
Intrinsic Value_5Y_min---22.025--------
Market Cap--958164200.000958164200.0000%1213358000.000-21%943914800.000+2%943914800.000+2%
Net Profit Margin---0.373-0.3730%-0.112-70%-0.184-51%-0.184-51%
Operating Margin----0%-0%-0.0550%-0.0550%
Operating Ratio--2.3052.3050%1.904+21%2.089+10%2.089+10%
Pb Ratio1.168+7%1.0861.0860%1.152-6%2.064-47%2.064-47%
Pe Ratio-6.195-8%-5.759-5.7590%-13.861+141%-7.732+34%-7.732+34%
Price Per Share23.870+7%22.19022.1900%28.100-21%21.860+2%21.860+2%
Price To Free Cash Flow Ratio9.463+7%8.7978.7970%-2.881+133%4.460+97%4.460+97%
Price To Total Gains Ratio-6.014-8%-5.591-5.5910%1.701-429%1.842-403%1.842-403%
Quick Ratio--0.1480.1480%0.011+1219%0.260-43%0.260-43%
Return On Assets---0.088-0.0880%-0.041-53%-0.086-2%-0.086-2%
Return On Equity---0.189-0.1890%-0.083-56%-0.298+58%-0.298+58%
Total Gains Per Share---3.969-3.9690%16.515-124%4.086-197%4.086-197%
Usd Book Value--10409287.40010409287.4000%12431665.800-16%6578743.080+58%6578743.080+58%
Usd Book Value Change Per Share---0.047-0.0470%0.195-124%0.048-197%0.048-197%
Usd Book Value Per Share--0.2410.2410%0.288-16%0.152+58%0.152+58%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.045-0.0450%-0.024-47%-0.033-28%-0.033-28%
Usd Free Cash Flow--1285303.2001285303.2000%-4969593.600+487%-412719.160+132%-412719.160+132%
Usd Free Cash Flow Per Share--0.0300.0300%-0.115+487%-0.010+132%-0.010+132%
Usd Free Cash Flow To Equity Per Share--0.0300.0300%-0.115+487%0.007+312%0.007+312%
Usd Market Cap--11306337.56011306337.5600%14317624.400-21%11138194.640+2%11138194.640+2%
Usd Price Per Share0.282+7%0.2620.2620%0.332-21%0.258+2%0.258+2%
Usd Profit---1963378.400-1963378.4000%-1032924.800-47%-1404424.200-28%-1404424.200-28%
Usd Revenue--5263873.8005263873.8000%9249784.000-43%8467982.080-38%8467982.080-38%
Usd Total Gains Per Share---0.047-0.0470%0.195-124%0.048-197%0.048-197%
 EOD+2 -4MRQTTM+0 -0YOY+8 -245Y+15 -1710Y+15 -17

3.3 Fundamental Score

Let's check the fundamental score of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.195
Price to Book Ratio (EOD)Between0-11.168
Net Profit Margin (MRQ)Greater than0-0.373
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.148
Current Ratio (MRQ)Greater than10.381
Debt to Asset Ratio (MRQ)Less than10.532
Debt to Equity Ratio (MRQ)Less than11.139
Return on Equity (MRQ)Greater than0.15-0.189
Return on Assets (MRQ)Greater than0.05-0.088
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose23.460
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to the  industry mean.
  • A Net Profit Margin of -37.3% means that ₹-0.37 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is -37.3%. The company is making a huge loss. -2
  • The TTM is -37.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-37.3%TTM-37.3%0.0%
TTM-37.3%YOY-11.2%-26.1%
TTM-37.3%5Y-18.4%-18.9%
5Y-18.4%10Y-18.4%0.0%
4.3.1.2. Return on Assets

Shows how efficient BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to the  industry mean.
  • -8.8% Return on Assets means that BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ generated ₹-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is -8.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.8%TTM-8.8%0.0%
TTM-8.8%YOY-4.1%-4.7%
TTM-8.8%5Y-8.6%-0.2%
5Y-8.6%10Y-8.6%0.0%
4.3.1.3. Return on Equity

Shows how efficient BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to the  industry mean.
  • -18.9% Return on Equity means BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ generated ₹-0.19 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is -18.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.9%TTM-18.9%0.0%
TTM-18.9%YOY-8.3%-10.6%
TTM-18.9%5Y-29.8%+11.0%
5Y-29.8%10Y-29.8%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is operating .

  • Measures how much profit BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.5%+5.5%
5Y-5.5%10Y-5.5%0.0%
4.3.2.2. Operating Ratio

Measures how efficient BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 2.31 means that the operating costs are ₹2.31 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is 2.305. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.305. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.305TTM2.3050.000
TTM2.305YOY1.904+0.401
TTM2.3055Y2.089+0.216
5Y2.08910Y2.0890.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 0.38 means the company has ₹0.38 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is 0.381. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.381. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.381TTM0.3810.000
TTM0.381YOY0.646-0.265
TTM0.3815Y0.719-0.339
5Y0.71910Y0.7190.000
4.4.3.2. Quick Ratio

Measures if BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to the  industry mean.
  • A Quick Ratio of 0.15 means the company can pay off ₹0.15 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is 0.148. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.148. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.148TTM0.1480.000
TTM0.148YOY0.011+0.136
TTM0.1485Y0.260-0.112
5Y0.26010Y0.2600.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to industry mean.
  • A Debt to Asset Ratio of 0.53 means that BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ assets are financed with 53.2% credit (debt) and the remaining percentage (100% - 53.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is 0.532. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.532. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.532TTM0.5320.000
TTM0.532YOY0.505+0.028
TTM0.5325Y0.661-0.128
5Y0.66110Y0.6610.000
4.5.4.2. Debt to Equity Ratio

Measures if BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to the  industry mean.
  • A Debt to Equity ratio of 113.9% means that company has ₹1.14 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The MRQ is 1.139. The company is able to pay all its debts with equity. +1
  • The TTM is 1.139. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.139TTM1.1390.000
TTM1.139YOY1.019+0.119
TTM1.1395Y2.496-1.358
5Y2.49610Y2.4960.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ generates.

  • Above 15 is considered overpriced but always compare BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ to the  industry mean.
  • A PE ratio of -5.76 means the investor is paying ₹-5.76 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The EOD is -6.195. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.759. Based on the earnings, the company is expensive. -2
  • The TTM is -5.759. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.195MRQ-5.759-0.436
MRQ-5.759TTM-5.7590.000
TTM-5.759YOY-13.861+8.103
TTM-5.7595Y-7.732+1.973
5Y-7.73210Y-7.7320.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The EOD is 9.463. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.797. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.797. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.463MRQ8.797+0.666
MRQ8.797TTM8.7970.000
TTM8.797YOY-2.881+11.678
TTM8.7975Y4.460+4.336
5Y4.46010Y4.4600.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 1.09 means the investor is paying ₹1.09 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$:

  • The EOD is 1.168. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.086. Based on the equity, the company is underpriced. +1
  • The TTM is 1.086. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.168MRQ1.086+0.082
MRQ1.086TTM1.0860.000
TTM1.086YOY1.152-0.066
TTM1.0865Y2.064-0.978
5Y2.06410Y2.0640.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,886,473
Total Liabilities1,004,330
Total Stockholder Equity882,143
 As reported
Total Liabilities 1,004,330
Total Stockholder Equity+ 882,143
Total Assets = 1,886,473

Assets

Total Assets1,886,473
Total Current Assets358,028
Long-term Assets1,528,441
Total Current Assets
Cash And Cash Equivalents 12,859
Net Receivables 138,759
Inventory 14,221
Other Current Assets 53
Total Current Assets  (as reported)358,028
Total Current Assets  (calculated)165,892
+/- 192,136
Long-term Assets
Property Plant Equipment 1,157,425
Long-term Assets Other 39
Long-term Assets  (as reported)1,528,441
Long-term Assets  (calculated)1,157,464
+/- 370,977

Liabilities & Shareholders' Equity

Total Current Liabilities940,424
Long-term Liabilities63,906
Total Stockholder Equity882,143
Total Current Liabilities
Short Long Term Debt 702,249
Accounts payable 10,314
Other Current Liabilities 27,674
Total Current Liabilities  (as reported)940,424
Total Current Liabilities  (calculated)740,237
+/- 200,187
Long-term Liabilities
Long-term Liabilities  (as reported)63,906
Long-term Liabilities  (calculated)0
+/- 63,906
Total Stockholder Equity
Total Stockholder Equity (as reported)882,143
Total Stockholder Equity (calculated)0
+/- 882,143
Other
Capital Stock431,800
Common Stock Shares Outstanding 43,180
Net Debt 689,390
Net Invested Capital 1,584,392
Net Working Capital -582,396
Property Plant and Equipment Gross 1,571,205



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
1,249,602
1,268,298
1,039,858
2,127,286
1,886,473
1,886,4732,127,2861,039,8581,268,2981,249,60200
   > Total Current Assets 
467,855
382,000
987,353
930,201
339,542
654,288
358,028
358,028654,288339,542930,201987,353382,000467,855
       Cash And Cash Equivalents 
0
0
4,078
9,850
12,269
46,429
12,859
12,85946,42912,2699,8504,07800
       Short-term Investments 
0
0
21,007
111,134
0
0
0
000111,13421,00700
       Net Receivables 
71,548
163,157
734,236
176,138
105
11,329
138,759
138,75911,329105176,138734,236163,15771,548
       Inventory 
3,715
17,217
144,392
517,189
134,904
362,497
14,221
14,221362,497134,904517,189144,39217,2173,715
       Other Current Assets 
60,781
55,152
83,605
115,890
31
40
53
534031115,89083,60555,15260,781
   > Long-term Assets 
0
0
262,249
338,097
700,315
1,472,994
1,528,441
1,528,4411,472,994700,315338,097262,24900
       Property Plant Equipment 
55,833
51,718
49,209
46,845
361,284
1,159,808
1,157,425
1,157,4251,159,808361,28446,84549,20951,71855,833
       Long-term Assets Other 
0
0
2
-1
0
-1
39
39-10-1200
> Total Liabilities 
0
0
942,829
1,063,560
699,440
1,073,755
1,004,330
1,004,3301,073,755699,4401,063,560942,82900
   > Total Current Liabilities 
141,339
125,252
884,754
1,007,075
640,907
1,012,639
940,424
940,4241,012,639640,9071,007,075884,754125,252141,339
       Short Long Term Debt 
0
0
322,223
30,384
272,934
778,850
702,249
702,249778,850272,93430,384322,22300
       Accounts payable 
2,874
4,180
441,843
435,315
147,932
8,694
10,314
10,3148,694147,932435,315441,8434,1802,874
       Other Current Liabilities 
133,742
113,765
110,606
532,585
5,608
28,200
27,674
27,67428,2005,608532,585110,606113,765133,742
   > Long-term Liabilities 
0
0
58,075
56,485
58,533
61,116
63,906
63,90661,11658,53356,48558,07500
       Long-term Liabilities Other 
0
0
1
0
-6
1
-1
-11-60100
> Total Stockholder Equity
0
0
306,773
204,738
340,418
1,053,531
882,143
882,1431,053,531340,418204,738306,77300
   Retained Earnings -662,114-495,726-408,189-227,062-125,026-56,851-14,283
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue446,091
Cost of Revenue-422,083
Gross Profit24,00824,008
 
Operating Income (+$)
Gross Profit24,008
Operating Expense-606,165
Operating Income-160,074-582,157
 
Operating Expense (+$)
Research Development0
Selling General Administrative9,884
Selling And Marketing Expenses0
Operating Expense606,1659,884
 
Net Interest Income (+$)
Interest Income4,734
Interest Expense-69,628
Other Finance Cost-968
Net Interest Income-65,862
 
Pretax Income (+$)
Operating Income-160,074
Net Interest Income-65,862
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-222,679-160,074
EBIT - interestExpense = -69,628
-166,388
-96,760
Interest Expense69,628
Earnings Before Interest and Taxes (EBIT)0-153,051
Earnings Before Interest and Taxes (EBITDA)-156,642
 
After tax Income (+$)
Income Before Tax-222,679
Tax Provision--56,291
Net Income From Continuing Ops-166,388-166,388
Net Income-166,388
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net065,862
 

Technical Analysis of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$. The general trend of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 26.70 < 27.50 < 30.30.

The bearish price targets are: 22.50 > 22.48 > 22.25.

Tweet this
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Moving Average Convergence/Divergence (MACD) ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$. The current adx is .

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Relative Strength Index (RSI) ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Stochastic Oscillator ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Commodity Channel Index (CCI) ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Chande Momentum Oscillator (CMO) ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Williams %R ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Average True Range (ATR) ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily On-Balance Volume (OBV) ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Money Flow Index (MFI) ChartBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose23.460
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ with someone you think should read this too:
  • Are you bullish or bearish on BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$

I send you an email if I find something interesting about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.


Comments

How you think about this?

Leave a comment

Stay informed about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$.

Receive notifications about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$ in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.